The Society for Neuro-Oncology announces new Editor-In-Chief of Neuro-Oncology

The Society for Neuro-Oncology is pleased to announce the appointment of Kenneth Aldape as the Editor-in-Chief of our flagship journal, Neuro-Oncology.  Dr. Aldape succeeds Patrick Wen, who stepped down as Editor-in-Chief after being elected by the membership of SNO to serve as the Society’s president.

SNO received a number of extremely strong submissions to its Call for Applications, which were reviewed by an ad hoc search committee comprised of David Schiff (Chair), Paul Brown, Antonio Chiocca, Patrick Wen, Gelareh Zadeh and Chas Haynes (ex officio).  Ultimately, the committee concluded that Dr. Aldape was the candidate best suited to lead the journal and unanimously voted in favour of him becoming Editor-in Chief.

Dr. Wen said of the announcement: “I am thrilled that Ken has assumed the role of Editor-in-Chief.  He has done an outstanding job serving for many years as one of the Executive Editors, so shifting into this new position should be a seamless process.  I am looking forward to seeing the journal reach new heights under his leadership!”

Neuro-Oncology is an international, peer-reviewed journal, dedicated to providing superior and rapid publication of original research articles, editorials, reviews, and letters on all aspects of the field of neuro-oncology.  Established in 1999 and published monthly by Oxford University Press since 2010, Neuro-Oncology is ranked 9th among all ranked clinical neurology journals, and 19th among other oncology journals.  In addition to SNO, the journal is also affiliated with the Japan Society for Neuro-Oncology (JSNO) and the European Association of Neuro-Oncology (EANO).

Commenting on his appointment, Dr. Aldape said: “It is a great honor to be named to this role.  Under Patrick’s guidance, as well as previous outstanding editorial leadership from Darell Bigner and Alfred Yung, the journal has grown in quality and reputation to become the premier journal in our field.  I am humbled and honored to be a part of this and hope to build on their outstanding efforts to grow the journal to even greater heights.  I am excited and looking forward to working with all members of the neuro-oncology community, including members of SNO, as well as EANO and JSNO, as we build the journal together”.  Continued Dr. Aldape: “One of the programs we would like to initiate is a series of ‘position papers’ on topics of great interest and/or controversy which are important to the science and care of patients with central nervous systems tumors, but for which more work is needed to generated data-driven decisions.  I hope to reach out to members of the neuro-oncology community to ask for contributions of your expertise for this important initiative.”

More information on Neuro-Oncology can be found here: